DAAs represent a significant advancement in the treatment of viral infections in children. Traditional antiviral therapies often come with significant side effects and lower efficacy, particularly in pediatric populations. DAAs, on the other hand, offer a more targeted approach with higher efficacy and a better side effect profile. This is crucial for children, as their developing bodies can be more sensitive to medications and their side effects.
